Sugarloaf Wealth Management, LLC Night Hawk Biosciences, Inc. Transaction History

Sugarloaf Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	BUY	$1.79 - $2.96 $379 - $627	212 Added 1.84%	11,712 $21,000
Q2 2022 Jul 12, 2022	BUY	$1.65 - $3.13 $2,475 - $4,695	1,500 Added 15.0%	11,500 $29,000
Q1 2022 Apr 25, 2022	BUY	$2.1 - $3.54 $2,415 - $4,071	1,150 Added 12.99%	10,000 $31,000
Q4 2021 Jan 20, 2022	BUY	$3.04 - $6.01 $1,520 - $3,005	500 Added 5.99%	8,850 $27,000
Q3 2021 Oct 20, 2021	BUY	$5.9 - $7.44 $5,015 - $6,324	850 Added 11.33%	8,350 $50,000
Q2 2021 Jul 20, 2021	BUY	$5.78 - $9.6 $7,803 - $12,960	1,350 Added 21.95%	7,500 $50,000
Q1 2021 Apr 19, 2021	BUY	$5.67 - $12.54 $18,444 - $40,792	3,253 Added 112.29%	6,150 $45,000
Q4 2020 Feb 03, 2021	BUY	$5.28 - $9.59 $15,296 - $27,782	2,897 New	2,897 $16,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.